foxo4 dri senolytic 2023 FOXO4-DRI For Sale (10mg) The disordered p53 transactivation domain
The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications Development of a novel senolytic by precise disruption of FOXO4 p53 complex eBioMedicine FOXO4 DRI alleviates RIPF. (A) Representative Western blot for the Download Scientific Diagram Frontiers FOXO4 DRI regulates endothelial cell senescence via the P53 signaling pathway
Pay in 4 interest-free payments of $5.62 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3



